Social network
Investors - Ensuring sustainable growth
Investors - Ensuring sustainable growth

Investors

Ensuring sustainable growth

Tools content (print, share, increase/decrease text size):

 

Key facts & figures

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare.

Solid financial performance in 2015

2015 Aggregate Company Sales*
€37,057m

+9.7% on a reported basis 
+2.2% at constant exchange rates (CER)

2015 Business EPS
€5.64

+8.5% on a reported basis
stable at CER

 

*including Animal Health Business which is reported on a single line in the consolidated income statements in accordance with IFRS 5 (Non-current assets held for sale and discontinued operations)
 

Performance in first 9 months 2016

9 months 2016 Aggregate Company Sales*
€27,063m

-1.3% on a reported basis 
+1.2% at constant exchange rates (CER)

9 months 2016 Business EPS
€4.43

+2.3% on a reported basis 
+5.8% at CER

 

*including Animal Health Business which is reported on a single line in the consolidated income statements in accordance with IFRS 5 (Non-current assets held for sale and discontinued operations)
 
 

© Sanofi 2004-2017 - All rights reserved - Update: January 04, 2017

  • Site complies with W3C WCAG 2.0 (new window, in english)